Royce & Associates LP Purchases Shares of 105,526 Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Royce & Associates LP purchased a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 105,526 shares of the company's stock, valued at approximately $4,862,000. Royce & Associates LP owned about 0.38% of Establishment Labs at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ESTA. Assenagon Asset Management S.A. bought a new position in shares of Establishment Labs in the fourth quarter worth about $12,898,000. Raymond James Financial Inc. bought a new position in shares of Establishment Labs in the fourth quarter worth about $5,494,000. Stonepine Capital Management LLC bought a new position in shares of Establishment Labs in the third quarter worth about $3,245,000. Bamco Inc. NY grew its holdings in shares of Establishment Labs by 13.6% in the third quarter. Bamco Inc. NY now owns 489,386 shares of the company's stock worth $21,176,000 after purchasing an additional 58,611 shares during the last quarter. Finally, Mudita Advisors LLP grew its holdings in shares of Establishment Labs by 19.0% in the third quarter. Mudita Advisors LLP now owns 354,801 shares of the company's stock worth $15,352,000 after purchasing an additional 56,700 shares during the last quarter. 72.91% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Stephens restated an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, Establishment Labs presently has a consensus rating of "Moderate Buy" and an average price target of $57.40.

Remove Ads

Establishment Labs Stock Up 0.5 %

NASDAQ:ESTA traded up $0.21 during mid-day trading on Friday, reaching $39.67. The company's stock had a trading volume of 493,686 shares, compared to its average volume of 421,014. Establishment Labs Holdings Inc. has a 1 year low of $28.16 and a 1 year high of $60.12. The stock has a fifty day moving average of $35.70 and a 200-day moving average of $40.86. The firm has a market capitalization of $1.14 billion, a PE ratio of -15.38 and a beta of 0.95. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The business had revenue of $44.51 million during the quarter, compared to analysts' expectations of $44.45 million. Equities research analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.